Literature DB >> 20205612

The immunological properties of stroma-free polyhemolysate containing catalase and superoxide dismutase activities prepared by polymerized bovine stroma-free hemolysate.

Hongli Zhu1, Qianqian Du, Chao Chen, Thomas Ming Swi Chang.   

Abstract

Crosslinking of ultrapure hemoglobin, crystalline catalase, and superoxide dismutase resulted in a soluble nanodimensional complex of polyhemoglobin-catalase-superoxide dismutase. A less expensive and more convenient way is to crosslink bovine stroma-free hemolysate (stroma-free hemolysate) that already contains hemoglobin, catalase, and superoxide dismutase into polyhemoglobin with catalase and superoxide dismutase activities (stroma-free polyhemolysate) [21]. The objective of the present study is to evaluate the immunological properties of this stroma-free polyhemolysate. Each of three groups of rats received weekly subcutaneous injections of one of the stroma-free polyhemolysate, stroma-free hemolysate, and saline for four weeks. One week after the four cycles of weekly immunization, serum and plasma were collected for C3a complement activation tests and Ouchterlony antibody-antigen precipitation tests, respectively. Results show that stroma-free polyhemolysate retained significant antioxidant enzyme activity. The C3a complement activation test and Ouchterlony test show that four weekly subcutaneous injections of bovine stroma-free polyhemolysate did not result in any immunological reaction in rats when tested this way.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20205612      PMCID: PMC3518482          DOI: 10.3109/10731191003634232

Source DB:  PubMed          Journal:  Artif Cells Blood Substit Immobil Biotechnol        ISSN: 1073-1199


  28 in total

1.  SEMIPERMEABLE MICROCAPSULES.

Authors:  T M CHANG
Journal:  Science       Date:  1964-10-23       Impact factor: 47.728

Review 2.  Therapeutic applications of polymeric artificial cells.

Authors:  Thomas Ming Swi Chang
Journal:  Nat Rev Drug Discov       Date:  2005-03       Impact factor: 84.694

Review 3.  50th anniversary of artificial cells: their role in biotechnology, nanomedicine, regenerative medicine, blood substitutes, bioencapsulation, cell/stem cell therapy and nanorobotics.

Authors:  Thomas Ming Swi Chang
Journal:  Artif Cells Blood Substit Immobil Biotechnol       Date:  2007

4.  The C terminus of the anaphylatoxin C3a generated upon complement activation represents a neoantigenic determinant with diagnostic potential.

Authors:  R Burger; G Zilow; A Bader; A Friedlein; W Naser
Journal:  J Immunol       Date:  1988-07-15       Impact factor: 5.422

5.  Purification and properties of human erythrocyte pyrimidine 5'-nucleotidase.

Authors:  J D Torrance; D Whittaker; E Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

6.  On the stability of bovine superoxide dismutase. The effects of metals.

Authors:  H J Forman; I Fridovich
Journal:  J Biol Chem       Date:  1973-04-25       Impact factor: 5.157

7.  Biosynthetic and structural studies of hemoglobin in a patient with congenital dyserythropoietic anemia type I.

Authors:  D R Harkness; L Villa; I Berman; J B Wilson; T H Huisman
Journal:  Hemoglobin       Date:  1977       Impact factor: 0.849

8.  The life-sustaining capacity of human polymerized hemoglobin when red cells might be unavailable.

Authors:  Steven A Gould; Ernest E Moore; David B Hoyt; Paul M Ness; Edward J Norris; Jeffrey L Carson; George A Hides; Ian H G Freeman; Richard DeWoskin; Gerald S Moss
Journal:  J Am Coll Surg       Date:  2002-10       Impact factor: 6.113

9.  Human polymerized hemoglobin for the treatment of hemorrhagic shock when blood is unavailable: the USA multicenter trial.

Authors:  Ernest E Moore; Frederick A Moore; Timothy C Fabian; Andrew C Bernard; Gerard J Fulda; David B Hoyt; Therese M Duane; Leonard J Weireter; Gerardo A Gomez; Mark D Cipolle; George H Rodman; Mark A Malangoni; George A Hides; Laurel A Omert; Steven A Gould
Journal:  J Am Coll Surg       Date:  2008-11-07       Impact factor: 6.113

10.  Blood catalsase polymorphism: some immunological aspects.

Authors:  R N Feinstein; H Suter; B N Jaroslow
Journal:  Science       Date:  1968-02-09       Impact factor: 47.728

View more
  3 in total

1.  Polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase: a novel biotechnology-based blood substitute that transports both oxygen and carbon dioxide and also acts as an antioxidant.

Authors:  Yuzhu Bian; Zhixia Rong; Thomas Ming Swi Chang
Journal:  Artif Cells Blood Substit Immobil Biotechnol       Date:  2011-06

2.  Novel Nanodimension artificial red blood cells that act as O2 and CO2 carrier with enhanced antioxidant activity: PLA-PEG nanoencapsulated PolySFHb-superoxide dismutase-catalase-carbonic anhydrase.

Authors:  Wei Gao; Yuzhu Bian; Thomas M S Chang
Journal:  Artif Cells Nanomed Biotechnol       Date:  2013-01-22       Impact factor: 5.678

3.  A novel nanobiotherapeutic poly-[hemoglobin-superoxide dismutase-catalase-carbonic anhydrase] with no cardiac toxicity for the resuscitation of a rat model with 90 minutes of sustained severe hemorrhagic shock with loss of 2/3 blood volume.

Authors:  Yuzhu Bian; Thomas Ming Swi Chang
Journal:  Artif Cells Nanomed Biotechnol       Date:  2014-10-09       Impact factor: 5.678

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.